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ABSTRACT
Objective: In silico approach has particularly drawn attention in providing a realistic representation needed to understand the fundamental 
molecular structure of a transporter. The importance of folate metabolism and role in the internalization of antifolates in eukaryotes have been 
studied extensively, but the structural study of folate transporters in Homo sapiens (HFT), Plasmodium falciparum (PFT), and Streptococcus sp. (SFT) 
is still lacking. This study was conducted to study and compare the structures of prokaryotic and eukaryotic folate transporters.
Methods: HFT, PFT, and SFT were queried using blast and sequences were retrieved using National Center for Biotechnology and Information (NCBI) 
databases. This was superseded by structural and functional prediction of transporters. The structure has been generated using Swiss model which was 
visualized using PyMol and validated by Procheck and ERRAT analysis along with the values of different secondary structures mapping to diverse sections 
of the Ramachandran plot. The structural and functional comparison was performed by PROSO, ProFunc, TM Score, Porewalker, TMHMM, and Protscale. 
Result: All the parameters for structural comparison suggest that H. sapiens folate transporter is 16.67% and 17.72% identical to Plasmodium and 
Streptococcus whereas Plasmodium is 21.59% identical to Streptococcus. The evaluation of transmembrane helices and hydrophobicity resulted in the 
presence of 1, 4, and 12 membrane-spanning segments with predicted US, UDUD, and UDS as pore shape in Plasmodium, Streptococcus, and humans.
Conclusion: Such folate receptors are the main targets for the specific conveyance of antifolates. The differences found between these species may 
offer possibilities for the development of new drugs in future.
Keywords: Human folate transporters, Plasmodium folate transporter, Streptococcus folate transporter, Structural study, Software.
INTRODUCTION
Folic acid (or folate) is an essential B group vitamin nutritionally 
important in synthesizing cofactors required for cell proliferation and 
tissue repair [1]. One of the major folates is tetrahydrofolate which 
is utilized in donating one-carbon units for thymidylate and purine 
nucleotide synthesis, conversion of homocysteine into methionine 
and interconversion of serine into glycine [2]. In addition to the role 
as a constituent of protein, it plays a major role in the synthesis of 
S-adenosylmethionine necessary for methylation of RNA, DNA, some 
neurotransmitter, phospholipid, and proteins like histones. Bacteria, 
protists, fungi, and plants synthesize folates de novo, but higher 
organisms such as animals and human beings lack key enzymes of 
synthesis pathway thus require them in the diet which implies the 
pivotal role of different types of folate transporters [3].
Folate transporter belongs to the major facilitator superfamily (MFS), 
largest known secondary transporters for the passage of a variety 
of ligands such as peptides, drugs, nucleotides, monosaccharides 
oligosaccharides, cations, and anions [4]. Folates are transported 
through three diverse types of transporters, including: (i) Reduced folate 
carrier (RFC) (SLC19A1): Which transports reduced folates specifically 
5 methyltetrahydrofolate to the systematic cells at neutral pH. 
Structurally, it is an integral protein with 12 transmembrane domains 
(TMDs) with amino and carboxyl-terminal at cytoplasmic side [5,6]. 
These receptors are located in placenta and significantly in lung, kidney, 
leukocytes, bone marrow, and some portions of the central nervous 
system. (ii) Proton-coupled folate transporter (PCFT): That pumps 
the protons down the electrochemical gradient for transportation of 
folates into cells at low pH, unlike RFC. Human PCFTs are located on 
chromosome 17q11.2 having 12 TMDs with cytosolic oriented C and 
N termini encoding 459 amino acids [7]. Functionally, they are active 
in apical brush border membrane of jejunum and duodenum besides 
the basolateral membrane of choroid plexus, kidney, and placenta [7,8]. 
(iii) Folate receptors: Which bind to diverse form of folate conjugates. 
There are three folate receptors - FRα, FRβ, and FRγ which are usually 
expressed in different cell membranes [9]. FRs uptake of cellular folate 
through invagination process and forms the endosome vesicle which on 
acidification dissociates into separate entities and exits the endosome 
by diffusion [10]. Both FRα and FRβ are functional in malignant tissues, 
thus are moieties for tumor target of toxins and cytotoxic agents.
The presence of folate synthesizing and salvage genes in Plasmodium 
falciparum and Streptococcus anginosus unlike human explain the 
difference and reflect at folate synthesizing proteins as the target of 
antifolates effectively used for the treatment of malaria and other 
infectious disease like abscesses.
This intriguing difference in the role of transporters in prokaryotes and 
eukaryotes reflects the structural and functional study between them.
Folate intake is an ATP dependent symport mechanism mediating 
folate transporters. Wang et al. reported such uptake as a saturable 
process inhibited by probenecid and furosemide [11]. These studies 
suggested the sensitivity of folate transporters in the presence of 
inhibitors thus highlighting the accessibility of folate transporters 
as a drug target explaining the importance of drug susceptibility and 
parasite survival. However, the structural and functional comparison of 
folate transporters between prokaryotes and eukaryotes has not been 
conducted yet making it a novel attempt.
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METHODS
Retrieval of sequences
The protein sequences of Homo sapiens folate transporter (HFT), 
P. falciparum (PFT), and Streptococcus anginosus (PFT) were retrieved 
from the NCBI databases. All the sequences were downloaded in FASTA 
format. Blastp [12] search homology with RCSB PDB database identifies 
the template. On the basis of query coverage, identities and E value, the 
template of folate transporter homolog of H. sapiens, P. falciparum, and 
S. anginosus were obtained from Blastp database.
Model generation and quality validation
Protein 3D homology models were obtained through Swiss model [13], 
a web server which computes models on the basis of ProMod3, by 
placing target sequence as input. The model with lowest Q means, Z 
score, and highest sequence identity were considered as the best 
model. Selected models were visualized by pymol and validated by 
several servers to check the stereochemical quality of constructed 
model such as Procheck [14] calculating ERRAT analysis, Z score [15], 
and the program verifying the protein structure based on statistics 
of non-bonded atom-atom interactions. The quality of models was 
further assessed by Ramachandran plot by RAMPAGE which shows the 
conformations of φ and ψ torsion angles of an amino acid along with 
the distribution of data points for structure validation [16].
Structural and functional study
Structural and functional study of transporter proteins was executed 
by studying various parameters such as amino acid composition, 
molecular weight, pI, atomic composition, extinction coefficient, 
instability index, aliphatic index, and grades average of hydropathicity 
using a web server tool named ProtParam server [17]. For prediction of 
transmembrane helices, TMHMM server 2.0 is considered, the output 
result of which is based on Hidden Markov Model predicts 97–98% 
correct helices along with the discrimination between soluble and 
membrane proteins [18]. Hydrophobicity analysis was accomplished 
using ProtScale (Kyte and Dolittle). Prediction of secondary structure 
was performed by a convenient tool which functions on structural 
and sequence-based method termed as Profunc [19]. For improved 
structural and functional analysis, ProFunc tool also reported binding 
site residues, cleft and nest analysis. Number of binding sites which 
may participate in ligand binding was figured out by DEPTH, a server 
dealing with the parameters such as ligand binding cavities and pKa 
of ionizable residues in proteins [20]. The characterized protein 
channel, pore shape, pore size, and pore axis were computed using fully 
automated tool named PoreWalker [20]. Leucine-rich repeats and motif 
scanning were carried out by leucine-rich repeats (LRR) Finder [21]. 
HOLLOW facilitates the cavity and channel prediction [22].
Refinement of models by energy minimization
Small errors in the constructed models may hinder its benefit in drug 
design and protein-protein interaction. To bring them closer to their 
native state, model refinement was done using 3D Refine by optimizing 
hydrogen bonding network and atomic level energy through MESHI 
program. Global test score (GDT_TA), high accuracy score (GDT_HA) 
at 1Å was examined to understand the quality of refined model with 
respect to its native structure [23].
Structural comparison of models between prokaryotes and 
eukaryotes
An efficient tool named iPBA was used for the structural comparison 
which aligns the protein structure based on PB substitution matrices 
and anchor-based alignment methodology [24]. Structural and 
functional comparison of all three transporter species was then 
tabulated involving the results of all the parameters including amino 
acid composition, molecular weight, root-mean-square deviation 
(RMSD) value difference, TMH, hydrophobicity, pore shape and size, 
secondary structures, binding sites and its residues, number of cavities 
and pockets, and leucine-rich repeats. Structural comparison was also 
done to predict the residues at putative protein interface and also 




The protein sequences of H. sapiens retrieved were 257 amino acids in 
length with accession number (AN_NP_057937.1), 505 amino acids in 
P. falciparum with accession number (PKC47564.1), 186 amino acids in 
S. auringosus with accession number (AIK78459.1).
Model features of HFT, PFT, and SFT: The selected template using 
Blastp for H. sapiens was crystal structure of FR alpha transporter (PDB 
ID: 5iq.6.A) with 100% sequence identity, Escherichia coli transport 
protein (PDB ID: 2aw0.1.B) for P. falciparum with 100% sequence 
identity, and ECF transporter (PDB ID: 5d3m.2.C) for S. auringosus with 
30% sequence identity. These template sequences were the input for 
a model generation (Fig. 1). The models were validated using ERRAT 
analysis scoring 98.8 in H. sapiens, 90.22 in P. falciparum, and 79.66 in 
S. auringosus. In addition, Z score, an energy-based qualifier to determine 
structural errors ranging −6.98 in H. sapiens, −9.69 in P. falciparum, and 
−2.39 in S. auringosus. These values are credible as it indicates negative 
scoring energy characteristic of TM regions. H. sapiens gave better 
results in perspective of Ramachandran plot stipulating zero number of 
residues in outlier region, 96% in favored region, and 3.9% in allowed 
region as compared to S. auringosus showing 0.5% residues in outlier 
region, 94.0% in favored region, and 5.4% in allowed region whereas 
P. falciparum showed 2.7% residues in outlier region, 90.5% in favored 
region, and 6.8% in allowed region. These verification studies validate 
the model to be stable.
Structural and functional analysis of folate transporters
Folate transporter belongs to highly conserved MFS which functions 
using electrochemical gradient. The physiochemical parameters of 
folate transporter protein of H. sapiens (HFT), P. falciparum (PFT), and 
S. auringosus (SFT) are tabulated in Table 1.
Analysis of amino acid composition reveals that all three of the proteins 
are leucine-rich in common whereas isoleucine is found to be highest in 
P. falciparum as compared to alanine and tryptophan in H. sapiens and 
valine in S. auringosus whereas atomic acid composition shows that all 
these proteins are rich in hydrogen and carbon. The charge on amino 
acid residues displays net positive charge on all the three proteins 
relating to highest extinction coefficient in H. sapiens as compared to 
P. falciparum and S. auringosus validating the tryptophan-rich human 
folate transporter. Highest instability coefficient in human folate 
transporter implies the most stable structure followed by S. auringosus 
and P. falciparum. Estimated lifespan was found similar for all the three 
proteins.
The 3D structure of each protein demonstrates the presence of N and 
C terminal domains having two-fold symmetry axis perpendicular to 
Fig. 1: In silico models of folate transporter generated by Swiss 
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the membrane plane. Each domain is further divided into TMH. The 
HFT comprise only 1TM of 27 amino acids while PFT has 12 TM of 257 
amino acids and SFT has 4TM of 101 amino acids. Since the number of 
amino acids exceeds 18, we suggest that all the folate transporters are 
transmembrane proteins. The probabilities for the N-terminus to be 
on cytoplasmic side for folate transporter of human, Plasmodium, and 
Streptococcus are 0.49, 0.933, and 0.07, respectively (Fig. 2). In human 
folate transporter, a higher number of amino acid lies on the negative side 
of hydropathy scale implying the hydrophilic nature of protein whereas 
a higher number of amino acids in Plasmodium Streptococcus and lies on 
the positive side of scale suggesting the hydrophobic character.
Secondary structure prediction results in HFT, PFT, and SFT indicated 
the number of helices (Fig. 3). The HFT secondary structure reveals 9 
alpha chains, 28 beta turns, 2 gamma turns, 7 helix-helix interactions, 
and 8 disulfides. The PFT structure has 11 alpha chains, 38 beta turns, 
10 gamma turns, 9 helix-helix interactions, and 7 beta hairpins whereas 
SFT structure indicates the presence of 11 alpha chains, 6 beta turns, 1 
gamma turns, and 23 helix-helix interactions.
We analyzed tertiary structure for cleft and binding sites using ProFunc 
server and found putative binding sites in the cytoplasmic region inside 
the transmembrane region in Plasmodium in contrast with human and 
Streptococcus having binding sites outside the transmembrane as shown 
in Fig. 4. ProFunc also predicts “nest” near putative phosphorylation 
site which is characteristic functional motifs. We also studied features 
of a pore to understand the geometry of the channel in these proteins. 
The pore is found to be cylinder shape in human whereas conical 
Table 1: Physiochemical features of HFT, PFT, SFT
Parameters HFT PFT SFT
Number of amino acids 257 505 186
Molecular weight 29819.3 58060.42 21000.44
Theoretical pI 8.30 8.05 9.85
Total number of negative charged residues 22 35 8
Total number positive charged residues 20 38 17
Formula of atomic composition C1334H1991N371O366S23 C2704H4192N620O736S28 C1005H1573N233O239S08
Total number of atoms 4085 8280 3058
Extinction coefficient 100920 52105 32430
Instability coefficient 41.69 34.80 35.54
Aliphatic composition 64.20 116.79 126.77
Estimated half-life 30 30 30
Grand average of hydropathy 0.418 0.490 0.801
H. sapiens: Homo sapiens, P. falciparum: Plasmodium falciparum, S. anginosus: Streptococcus anginosus, HFT: Folate transporter of H. sapiens, FPT: P. falciparum, 
SFT: S. anginosus
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shape in Plasmodium and diamond shape in Streptococcus resulting in 
unique types of pore from each other by which ligand may pass. All are 
reported to have pore size as 3 Å (Fig. 5).
Structural refinement of transporters
Superimposition of energy minimized structures with that of modeled 
structure result in the fluctuation of RMSD value from 2.90 to 0.13 in 
H. sapiens while 0.14–2.65 and the highest reduction in RMSD value were 
found to be in S. auringosus, 3.95–0.14. Such reduction in RMSD value 
involves the elimination of 5 atoms from modeled structure in human 
and Streptococcus whereas 7 atoms in Plasmodium. Higher reduction in 
RMSD values in S. auringosus is subjected to the highest 3D refine score 
and Mol Prob score followed by H. sapiens and P. falciparum (Table 2).
Structural comparison between human, Plasmodium, and 
Streptococcus folate transporter
All the parameters studied under the structural analysis have been 
compared and tabulated between HFT, PFT, and SFT. Structural 
comparison suggests that H. sapiens folate transporter is 16.67% 
and 17.72% identical to Plasmodium and Streptococcus whereas 
Plasmodium is 21.59% identical to Streptococcus. Although all the 
membrane proteins are rich in leucine, higher positive residues in 
human make it more compatible for antimicrobial activity and hemolytic 
activity. In fact presence of high amount of valine in Streptococcus 
dramatically reduces toxicity and therapeutic index. Presence of 3 
LRRs in Plasmodium and 1 each in human and Streptococcus indicate 
the importance of protein phosphorylation playing a fundamental 
role in drug transport across the cell membrane. Previous studies 
reported the effect of altering phosphorylation sites in mammalian 
transport homolog, PfMDR1 on drug action. All the three proteins 
have conserved residues that make up the predicted nest. No. of nest 
in humans, Plasmodium, and Streptococcus are 8, 5, and 1 which are 
functional motifs. Being eukaryotic, human, and Plasmodium folate 
transporter share some signature sequences in two cytosolic loops in 
MFS family.
In respect of TMH, Plasmodium comprises 12 TM with N and C terminus 
on cytosolic side validating the same in MFS proteins. Hydrophobicity of 
human folate transporter as compared to Plasmodium and Streptococcus 
predicts the rate of protein crossing the membrane. Greater number 
of binding site residues and solvent accessible areas in Streptococcus 
higher will be the affinity of molecules to bind. The different shapes of 
the pore of transporter protein will help in designing unique ligands.
Prediction of the cavity is important in ligand binding, molecular transport, 
and enzyme catalysis. 103 number of binding residues in Streptococcus 
Table 2: Scoring by 3d refine of HFT, PFT, SFT








Human 12895.2 0.131 1.849 0.13
Plasmodium 1.0000 0.999 2.082 0.14
Streptococcus 13455.6 0.142 3.17 0.14
RMSD: Root-mean-square deviation, H. sapiens: Homo sapiens, 
P. falciparum: Plasmodium falciparum, S. anginosus: Streptococcus anginosus, 
HFT: Folate transporter of H. sapiens, FPT: P. falciparum, SFT: S. anginosus
Fig. 4: Binding site prediction by profunc (a): Homo sapiens, 
(b): Plasmodium falciparum, (c): Streptococcus auringosus
cba
Fig. 5: Pore shape by porewalker (a): Homo sapiens, 
(b): Plasmodium falciparum, (c): Streptococcus auringosus
cba
Fig. 6: Cavity prediction by HOLLOW (a): Homo sapiens, 
(b): Streptococcus auringosus, (c): Plasmodium falciparum
cba
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as compared to 33 in human and 31 in Plasmodium indicated the better 
chance of ligand binding and surpassing the molecule (Fig. 6).
Alignment of models by iPBA of human with Plasmodium and 
Plasmodium with Streptococcus folate transporter aligns only 31 number 
of residues as compared to 53 when alignment was done between 
Human and Streptococcus confirming the wide difference in HFT and 
PFT as compared to HFT and SFT. These differences in folate transporter 
proteins can prove to be the best target of drug designing (Fig. 7).
SPPIDER server helped us to distinguish the most likely interface sites 
at the surface of proteins. These accessible areas are well-studied 
considering parameters such as van der wall surfaces, dot surfaces, and 
mol prob surfaces (Fig. 8). The most likely interface sites were attributed 
to the element whose accessible areas are greater than others.
CONCLUSION
This study integrates structural and statistical approaches for modeling 
of folate transporters. These structure models are in agreement with 
other crystallographic structures. This structural comparison study 
will enhance our understanding about folate transporters in different 
species. Such differences between eukaryotic and prokaryotic folate 
transporters can suggest several binding and interaction sites for 
drug designing and help us to identify drug targets for therapeutic 
development.
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